JPRN-UMIN000024603已完成未知
A study for the efficacy of BSL-0051 and BSL-0052 on healthy skin - A study for the efficacy of BSL-0051 and BSL-0052 on healthy skin
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 59years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.Panelists with illnesses or diseases which in the opinion of the investigators, might interfere with the conduct of the study or the interpretation of results. Panelists especially with any skin irritation, skin condition (such as rosacea, eczema, atopic dermatitis, or psoriasis), or severe acne on their faces. 2.Panelists who take any supplements, OTC or prescription medications, especially anti-inflammation agents, anti-bacterial agents, analgesic agents, hormonal agents, laxative agents, intestinal agents, etc. 3.Panelists under the care of a doctor taking prescription medication (topical) for any facial skin issues. 4.Panelists with allergy or sensitivity to any facial care product, facial moisturizer, facial cleanser, pore strip, or to any specific ingredient or fragrance used in these types of products. 5.Panelists who refrain from sun exposure, tanning beds, sunless tanners, and skin lightening products until the study completes. 6.Panelists currently participating in, or scheduled to participate in, another facial study during the study period. 7.Panelists having any conditions which in the opinion of the investigators, might interfere with the conduct of the study or the interpretation of results.
研究者
相似试验
已完成
不适用
The clinical study to examine efficacies of BSL5-170327C and BSL5-170327S on healthy skiHealthy adultsJPRN-UMIN000027155Kao Corporation40
已完成
2 期
Comapring impact of Bles versus Curosurf in respiratory distress of preterm infantsRespiratory Dystress Syndrome.P.22.0Hyaline membrane diseaseIRCT2017021418994N3Vice Chancellor of Kerman University of Medical Sciences240
招募中
2 期
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological MalignanciesCervical CancerNCT05990803Sichuan Baili Pharmaceutical Co., Ltd.130
进行中(未招募)
1 期
A 2 year study to investigate belimumab in membranous nephropathyIdiopathic Membranous Nephropathy (IMN)MedDRA version: 15.0 Level: LLT Classification code 10027170 Term: Membranous nephropathy System Organ Class: 10038359 - Renal and urinary disordersEUCTR2011-000242-38-GBGlaxoSmithKline Research & Development Ltd
进行中(未招募)
不适用
A 2 year study to investigate belimumab in membranous nephropathyEUCTR2011-000242-38-CZGlaxoSmithKline Research & Development Ltd94
